Interview: Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer. FILE PHOTO: World's biggest maker of cancer drugs Roche CEO Severin Schwan attends a news conference in Basel, Switzerland February 1, 2017. REUTERS/Ruben Sprich“We have a real chance to be at the forefront here,” Chief Executive Severin Schwan said on Wednesday. “Our ambition is to become a clear leader in ...